Search results
Results from the WOW.Com Content Network
Infectious mononucleosis (IM, mono), also known as glandular fever, is an infection usually caused by the Epstein–Barr virus (EBV). [2] [3] Most people are infected by the virus as children, when the disease produces few or no symptoms. [2] In young adults, the disease often results in fever, sore throat, enlarged lymph nodes in the neck, and ...
There are several forms of Epstein–Barr virus (EBV) infection. These include asymptomatic infections, the primary infection, infectious mononucleosis, and the progression of asymptomatic or primary infections to: 1) any one of various Epstein–Barr virus-associated lymphoproliferative diseases such as chronic active EBV infection, EBV+ hemophagocytic lymphohistiocytosis, Burkitt's lymphoma ...
Yes, you can get norovirus twice. “People can get infected with norovirus countless times,” says infectious disease expert Amesh A. Adalja, M.D., a senior scholar at the Johns Hopkins Center ...
Epstein–Barr virus infectious mononucleosis (Mono) Diagnostic modalities for infectious mononucleosis include: Person's age, with highest risk at 10 to 30 years. Medical history, such as close contact with other people with infectious mononucleosis; Physical examination, including palpation of any enlarged lymph nodes in the neck, or enlarged ...
After the latency period (but before clinical infection) the infected person can transmit the disease without signs of any symptoms. Such infection is called subclinical infection. Incubation period (also known as the latent period or latency period ) is the time elapsed between exposure to a pathogenic organism, a chemical, or radiation , and ...
Epstein–Barr virus–associated lymphoproliferative diseases (also abbreviated EBV-associated lymphoproliferative diseases or EBV+ LPD) are a group of disorders in which one or more types of lymphoid cells (a type of white blood cell), i.e. B cells, T cells, NK cells, and histiocytic-dendritic cells, are infected with the Epstein–Barr virus (EBV).
For premium support please call: 800-290-4726 more ways to reach us
They are also expensive, risk causing resistance to antiviral agents, and (in 1% to 10% of cases) can cause unpleasant side effects. [1] Several clinical trials for a vaccine were conducted in 2006–2008. [4] [5] [6] The viral proteins Gp350/220 are a primary target, [7] but this would only block infection of B cells, not epithelial cells.